US01625V1044 - Common Stock

Overall **ALHC** gets a fundamental rating of **2** out of 10. We evaluated **ALHC** against 114 industry peers in the **Health Care Providers & Services** industry. **ALHC** has a bad profitability rating. Also its financial health evaluation is rather negative. **ALHC** is valued quite expensively, but it does show have an excellent growth rating.

The reported operating cash flow has been mixed in the past 5 years: **ALHC** reported negative operating cash flow in multiple years.

The **Return On Assets** of **ALHC** (**-20.82%**) is worse than **78.07%** of its industry peers.

Looking at the **Return On Equity**, with a value of **-125.84%**, **ALHC** is doing worse than **78.07%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -20.82% | ||

ROE | -125.84% | ||

ROIC | N/A |

ROA(3y)-26.52%

ROA(5y)-21.89%

ROE(3y)-73.64%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

The **Gross Margin** of **ALHC** (**10.45%**) is worse than **77.19%** of its industry peers.

The **Profit Margin** and **Operating Margin** are not available for **ALHC** so they could not be analyzed.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 10.45% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-13.99%

GM growth 5YN/A

The number of shares outstanding for **ALHC** has been increased compared to 1 year ago.

An Altman-Z score of **3.93** indicates that **ALHC** is not in any danger for bankruptcy at the moment.

Looking at the **Altman-Z score**, with a value of **3.93**, **ALHC** belongs to the top of the industry, outperforming **81.58%** of the companies in the same industry.

A Debt/Equity ratio of **1.84** is on the high side and indicates that **ALHC** has dependencies on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.84 | ||

Debt/FCF | N/A | ||

Altman-Z | 3.93 |

ROIC/WACCN/A

WACC9.1%

A Current Ratio of **1.60** indicates that **ALHC** should not have too much problems paying its short term obligations.

Looking at the **Current ratio**, with a value of **1.60**, **ALHC** is in line with its industry, outperforming **59.65%** of the companies in the same industry.

A Quick Ratio of **1.60** indicates that **ALHC** should not have too much problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **1.60**, **ALHC** is in the better half of the industry, outperforming **63.16%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.6 | ||

Quick Ratio | 1.6 |

The **Earnings Per Share** has grown by an nice **8.33%** over the past year.

Measured over the past years, **ALHC** shows a very strong growth in **Revenue**. The Revenue has been growing by **23.88%** on average per year.

EPS 1Y (TTM)8.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%22.22%

Revenue 1Y (TTM)43.46%

Revenue growth 3Y23.88%

Revenue growth 5YN/A

Sales Q2Q%51.61%

Based on estimates for the next years, **ALHC** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **20.71%** on average per year.

EPS Next Y10.5%

EPS Next 2Y15.4%

EPS Next 3Y13.5%

EPS Next 5Y20.71%

Revenue Next Year48.45%

Revenue Next 2Y38.49%

Revenue Next 3Y32.82%

Revenue Next 5Y24.07%

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

The **Price/Earnings Ratio** is negative for **ALHC**. In the last year negative earnings were reported.

Also next year **ALHC** is expected to report negative earnings again, which makes the also the **Forward Price/Earnings** Ratio negative.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | N/A | ||

EV/EBITDA | N/A |

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y15.4%

EPS Next 3Y13.5%

No dividends for **ALHC**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**ALIGNMENT HEALTHCARE INC**

NASDAQ:ALHC (11/14/2024, 8:02:49 PM)

After market: 12.83 0 (0%)**12.83**

**+0.05 (+0.39%) **

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.46B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | N/A | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -20.82% | ||

ROE | -125.84% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 10.45% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover3.56

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.84 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.6 | ||

Quick Ratio | 1.6 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)8.33%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y10.5%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)43.46%

Revenue growth 3Y23.88%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y